Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPOCH vs. NHL-15 in Previously Untreated Aggressive NHL
NCT00005964Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- May 2000
- Primary completion
- Mar 2006
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin, etoposide, vincristine, cyclophosphamide, prednisone in non-Hodgkin lymphoma (NHL), sponsored by Cancer and Leukemia Group B. Started May 2000; status: completed.
02
Drugs
doxorubicinetoposidevincristinecyclophosphamideprednisone
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00005964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005964.